Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC) AstraZeneca Pharma India Ltd. (AstraZeneca India), a science-led biopharmaceutical company, announced it has received approval from the Central Drugs Standard Control Organisation (CDSCO) for its cancer drug Tremelimumab Concentrate
AstraZeneca Pharma India Ltd. (AstraZeneca India), a leading biopharmaceutical company, announced the appointment of Bhavana Agrawal as Chief Finance Officer (CFO) with effect from October 1, 2023, following a transition period. She succeeds Rajesh Marwaha, who is retiring as CFO and full-time director of the
AstraZeneca Pharma India Ltd a leading biopharmaceutical company announces a change in its leadership with the appointment of Dr. Sanjeev Panchal as Country President & Managing Director, AstraZeneca Pharma India Ltd with effect from 1st January 2023. Sanjeev has been with AstraZeneca for 19 years and
Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.
